Funding for this research was provided by:
Janssen Pharmaceuticals, Germany (ReCAP DRV-I-15-DEU-004-V03)
Article History
Received: 8 September 2018
Revised: 5 November 2018
Accepted: 9 November 2018
First Online: 9 January 2019
Compliance with ethical standards
:
: Gabriele Arendt received financial support from Janssen-Cilag GmbH, Germany and from ViiV Healthcare and honoraria for lectures and consultancies from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag GmbH, Germany and MSD. All the other authors declare that they have no conflict of interest.